General MedicationsINJECTIONGeneric
TICAR
TICARCILLIN DISODIUM
Standard Dose
EQ 6GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview TICAR is listed in Drugs@FDA under application 050497 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient TICARCILLIN DISODIUM Form and strength INJECTABLE;INJECTION - EQ 6GM BASE/VIAL Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2003-01-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview TICAR is listed in Drugs@FDA under application 050497 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TICARCILLIN DISODIUM Form and strength INJECTABLE;INJECTION - EQ 6GM BASE/VIAL Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2003-01-03 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.